NYSE:ELANPharmaceuticals
How Elanco Animal Health's Board Transition and Chairman Retirement Will Impact Elanco Animal Health (ELAN) Investors
Elanco Animal Health has announced that founding Chairman R. David Hoover and Dr. Deborah Kochevar will not stand for re-election at the May 2026 Annual Meeting, reducing the Board to nine directors and marking an important leadership transition following the company’s separation from Eli Lilly.
With Hoover’s IPO-era governance experience and Kochevar’s oversight of the Innovation, Science, and Technology committee both stepping away, investors may focus more closely on how new and remaining...